Page last updated: 2024-10-23

biperiden and Cognition Disorders

biperiden has been researched along with Cognition Disorders in 6 studies

Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research Excerpts

ExcerptRelevanceReference
"Discontinuation of long-term biperiden use may be warranted in patients with schizophrenia treated with SGAs, as it may improve cognitive function, subjective QOL, and psychiatric symptoms with no significant adverse effects."7.77Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia. ( Anai, K; Arai, J; Funamoto, Y; Ito, Y; Kaneda, Y; Kitajima, R; Kubota, H; Miyake, N; Miyamoto, S; Ogino, S; Ojima, K; Tadokoro, M; Tatsunami, S; Tenjin, T; Tsukahara, S; Yamaguchi, N, 2011)
"Discontinuation of long-term biperiden use may be warranted in patients with schizophrenia treated with SGAs, as it may improve cognitive function, subjective QOL, and psychiatric symptoms with no significant adverse effects."3.77Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia. ( Anai, K; Arai, J; Funamoto, Y; Ito, Y; Kaneda, Y; Kitajima, R; Kubota, H; Miyake, N; Miyamoto, S; Ogino, S; Ojima, K; Tadokoro, M; Tatsunami, S; Tenjin, T; Tsukahara, S; Yamaguchi, N, 2011)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Szczodry, O1
van der Staay, FJ1
Arndt, SS1
Veselinović, T1
Vernaleken, I1
Janouschek, H1
Kellermann, T1
Paulzen, M1
Cumming, P1
Gründer, G1
Ogino, S1
Miyamoto, S1
Tenjin, T1
Kitajima, R1
Ojima, K1
Miyake, N1
Funamoto, Y1
Arai, J1
Tsukahara, S1
Ito, Y1
Tadokoro, M1
Anai, K1
Tatsunami, S1
Kubota, H1
Kaneda, Y1
Yamaguchi, N1
Klinkenberg, I1
Blokland, A1
Drimer, T1
Shahal, B1
Barak, Y1
Cuesta, MJ1
Peralta, V1
Zarzuela, A1

Trials

1 trial available for biperiden and Cognition Disorders

ArticleYear
Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients.
    International clinical psychopharmacology, 2004, Volume: 19, Issue:1

    Topics: Aged; Antipsychotic Agents; Biperiden; Cognition Disorders; Dose-Response Relationship, Drug; Drug A

2004

Other Studies

5 other studies available for biperiden and Cognition Disorders

ArticleYear
Modelling Alzheimer-like cognitive deficits in rats using biperiden as putative cognition impairer.
    Behavioural brain research, 2014, Nov-01, Volume: 274

    Topics: Animals; Biperiden; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; M

2014
Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers.
    Psychopharmacology, 2015, Volume: 232, Issue:9

    Topics: Adolescent; Adult; Attention; Biperiden; Cognition; Cognition Disorders; Female; Healthy Volunteers;

2015
Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia.
    Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jan-15, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Biperiden; Cognition Disorders; Drug Administration Schedul

2011
A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment.
    Psychopharmacology, 2011, Volume: 215, Issue:3

    Topics: Animals; Behavior, Animal; Biperiden; Cognition Disorders; Disease Models, Animal; Dose-Response Rel

2011
Empirical validation of competing definitions of schizophrenia: a poly-diagnostic study of cognitive impairment in non-affective psychosis.
    Schizophrenia research, 2007, Volume: 95, Issue:1-3

    Topics: Adult; Analysis of Variance; Antipsychotic Agents; Biperiden; Cognition Disorders; Diagnosis, Differ

2007